Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The myometrial muscle cell membrane potential is a critical determinant of uterine smooth muscle excitability and contractility. Magnesium ions (Mg²⁺) play a significant modulatory role in this process by influencing the ionic currents across the myometrial cell membrane, particularly those involving calcium (Ca²⁺) and potassium (K⁺) ions. Mg²⁺ modulates these processes by competing with Ca²⁺ for entry into cells, inhibiting voltage-dependent Ca²⁺ channels, and stabilizing the negative resting membrane potential, making depolarization less likely and thus reducing contractility. Magnesium supplementation is clinically used as a tocolytic agent to suppress premature labor by decreasing uterine contractility through its effects on cellular excitability and calcium handling.
Magnesium modulates myometrial contractility by hyperpolarizing the cell membrane, inhibiting voltage-gated Ca2+ channels, and reducing intracellular calcium availability.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myometrial Muscle Cell Membrane Potential Modulation (for Magnesium) (N/A).